GLP-1 mimetic therapy improved global left ventricular (LV) function in patients with acute myocardial infarction and LV dysfunction after successful reperfusions [56], and ischemia in patients with coronary artery disease [57]. This evidence concerns the gene GLP1R and ischemia.